URINE SCREEN OF TYPE 2 DM WITH AND WITHOUT NEPHROPATHY FOR INFLAMMATORY MARKERS
URINE SCREEN OF TYPE 2 DM WITH AND WITHOUT NEPHROPATHY FOR INFLAMMATORY MARKERS
批准号:
7205500
负责人:
KAMBIZ KALANTARI
金额:
$0.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-03-01 至 2006-02-28
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ASSESSMENT OF CHANGES IN RENAL CORTICAL AND MEDULLARY BLOOD FLOW BY CONTRAST U/S
-
批准号:7951469
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2009
-
负责人:KAMBIZ KALANTARI
-
依托单位:
URINE SCREEN OF TYPE 2 DM WITH AND WITHOUT NEPHROPATHY FOR INFLAMMATORY MARKERS
-
批准号:7951459
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2009
-
负责人:KAMBIZ KALANTARI
-
依托单位:
Adenosine 2A Receptor Agonist in Diabetic Nephropathy
-
批准号:7993837
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2009
-
负责人:KAMBIZ KALANTARI
-
依托单位:
URINE SCREEN OF TYPE 2 DM WITH AND WITHOUT NEPHROPATHY FOR INFLAMMATORY MARKERS
-
批准号:7718539
-
项目类别:
-
资助金额:$1.03万
-
财政年份:2008
-
负责人:KAMBIZ KALANTARI
-
依托单位:
ASSESSMENT OF CHANGES IN RENAL CORTICAL AND MEDULLARY BLOOD FLOW BY CONTRAST U/S
-
批准号:7718553
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2008
-
负责人:KAMBIZ KALANTARI
-
依托单位:
Adenosine 2A Receptor Agonist in Diabetic Nephropathy
-
批准号:7455287
-
项目类别:
-
资助金额:$13.08万
-
财政年份:2007
-
负责人:KAMBIZ KALANTARI
-
依托单位:
Adenosine 2A Receptor Agonist in Diabetic Nephropathy
-
批准号:7895818
-
项目类别:
-
资助金额:$13.08万
-
财政年份:2007
-
负责人:KAMBIZ KALANTARI
-
依托单位:
Adenosine 2A Receptor Agonist in Diabetic Nephropathy
-
批准号:7624687
-
项目类别:
-
资助金额:$13.08万
-
财政年份:2007
-
负责人:KAMBIZ KALANTARI
-
依托单位:
Adenosine 2A Receptor Agonist in Diabetic Nephropathy
-
批准号:8111822
-
项目类别:
-
资助金额:$13.08万
-
财政年份:2007
-
负责人:KAMBIZ KALANTARI
-
依托单位:
URINE SCREEN OF TYPE 2 DM WITH AND WITHOUT NEPHROPATHY FOR INFLAMMATORY MARKERS
-
批准号:7606681
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2007
-
负责人:KAMBIZ KALANTARI
-
依托单位:
ASSESSMENT OF CHANGES IN RENAL CORTICAL AND MEDULLARY BLOOD FLOW BY CEU
-
批准号:7606700
-
项目类别:
-
资助金额:$0.89万
-
财政年份:2007
-
负责人:KAMBIZ KALANTARI
-
依托单位:
国内基金
海外基金
基于CRISPR-Screen模型对肿瘤相关巨噬细胞通过GFRA1非经典途径促进胃癌肝转移的机制探索
-
批准号:--
-
项目类别:面上项目
-
资助金额:54.7万元
-
批准年份:2021
-
负责人:张子臻
-
依托单位: